Redmile Group’s Bristol-Myers Squibb BMY Stock Holding History

Redmile Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-449,442	Closed	-$31.2M	–	74
2023 Q1	$31.2M	Buy	+449,442	New	+$31.7M	1.35%	26
2020 Q1	–	Sell	-1,800,800	Closed	-$116M	–	70
2019 Q4	$116M	Sell	1,800,800 -451,800	-20%	-$25.9M	2.76%	11
2019 Q3	$114M	Buy	2,252,600 +583,200	+35%	+$27.4M	3.82%	7
2019 Q2	$75.7M	Buy	1,669,400 +69,700	+4%	+$3.25M	2.14%	13
2019 Q1	$76.3M	Buy	1,599,700 +745,000	+87%	+$37.1M	2.23%	16
2018 Q4	$44.4M	Buy	+854,700	New	+$45.9M	1.79%	18
2014 Q2	–	Sell	-418,500	Closed	-$21.7M	–	50
2014 Q1	$21.7M	Buy	418,500 +17,630	+4%	+$938K	2.6%	12
2013 Q4	$21.3M	Buy	+400,870	New	+$20.4M	2.63%	13

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Redmile Group's BMY Position: Q2 2023 in Review

Redmile Group sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 449,442 shares — an estimated $31.2M sold.

Redmile Group first reported a position in BMY in Q4 2013 and held it in 8 quarters. The position peaked at $116M in Q4 2019. 2,482 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Redmile Group reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Redmile Group sold 449,442 Bristol-Myers Squibb shares in Q2 2023, an estimated $31.2M.
Redmile Group first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 8 quarters.
Redmile Group's Bristol-Myers Squibb position peaked at $116M in Q4 2019.
2,482 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Redmile Group's 13F filing for Q2 2023, filed 14 Aug 2023.